Roche Stories

Roche at the ASCO Annual Meeting 2018

Learn how we are working to help define the personalised cancer patient journeys of tomorrow.

Getting over the ups and downs

Dr Gallia Levy, Associate Group Medical Director at Roche, shares her perspective on the need for sustained bleeding protection in haemophilia A.

A mosaic of life after cancer

Stories of survival not only provide hope to cancer patients, but they also remind oncologists why they work so hard to find new treatments.

Meet Amrita, Bioinformatics Research Leader at Pleasanton, CA

"The sky is the limit when it comes to learning about new domains and extending your skills."

Partnering to improve cancer care in the Middle East

Peter Hug, Head of Roche Pharma EEMEA Region shares his perspective on partnering to solve cancer challenges in emerging markets.

Diversity is personal

Diversity and inclusion means something different for each employee.

Haemophilia A to Z

Learn about haemophilia A through the eyes of patients, caregivers and experts.

The measure of you

Explore how digital biomarkers are changing the way we understand health.

​Meet Cheng-Yuk, Principal Scientist I at Pleasanton, CA

It is truly a diversified environment. From the interdisciplinary education to the multi-cultural workforce, I strongly believe our collective experiences and passion will drive the innovation engine to develop the next meaningful diagnostics solution for patients.

Before we have a molecule, we have a technology

Next-generation antibody therapeutics could revolutionise cancer treatment. Driving discovery is CrossMAb technology, a simple platform for complex molecules.

Relapsing multiple sclerosis: Unravelling the maze

Explore how the patient pathway for people living with relapsing MS has changed over the past 20 years.

Progress in haemophilia: a personal perspective

The haemophilia community is united and strong. Find out more about the haemophilia community and progress being made in the field from Brian O’Mahony, Chief Executive of the Irish Haemophilia Society.

A pathway to hope for cancer patients

Barriers to accessing healthcare in Kenya include poor diagnosis and inadequate funding. Public-private partnerships aim for innovative and sustainable solutions.

Responding to new public health concerns

We are faced not only with existing infectious diseases but also the rise of new ones.

Sustainability at Roche: Our impact

Engaging with stakeholders is crucial to create sustainable value. Stakeholder engagement enables us to jointly develop solutions.

Trailblazing women at Roche

Discover how Roche has been advancing gender equality since 1896: There have always been women who inspired us by questioning the status quo.

Highlights Annual Report 2017

Read the incredible stories behind the numbers.

Bringing patient support to a rare disease

Learn how we are breaking down barriers that prevent patients from joining clinical trials for spinal muscular atrophy.

Living with MS: My Story

Felix, who lives with relapsing MS and Craig, who lives with primary progressive MS, talk about the impact of the disease on their daily lives.

Partnering in a digital era

Collaborations between healthcare and technology companies are driving the future of healthcare

Unconventional wisdom

How challenging the status quo led to the discovery of the B cell as a new target in MS.

Partnership to improve cancer care in Sudan

The partnership builds a cornerstone to fight breast and blood cancers by providing people access to innovative biotech medicines and diagnostic solutions.

Roche at J.P. Morgan Healthcare Conference

Collaborating to drive the future of personalised healthcare

‘Accelerators and brakes’ to restore immune balance

Roche strategy in Immunology is to make use of the growing scientific understanding of immune pathways and to selectively manipulate these in order to restore immune balance.

Increasing access to healthcare is a global challenge

Finding sustainable solutions to the barriers to healthcare can only be achieved through collaboration.

Boston biotech

Our local partners are helping to shape the future of healthcare.

Investors reporting center

The NT-proBNP Story

Biomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.

Improving access to hepatitis treatment in Egypt

Comprehensive access to cancer treatment in Dubai

Having it all at Roche

Addressing the lack of cancer care in Pakistan

A platform for supporting cancer patients in India

India does not have a centralised healthcare funding body and access to medicines is not universal.

Improving cancer care in Bosnia and Herzegovina

Women’s health

No matter what stage of life or part of the world a woman is in, knowledge is power.

Pregnancy after preeclampsia

Is it safe to have another baby?

Our access to healthcare initiatives

Explore some of our access projects from around the globe.

Increasing access to healthcare

Groundbreaking advances in medical science are only meaningful when they reach the people who need them.

Our approach to sustainability

Let’s talk fertility

Women and their bodies may have very different ideas about the right time to have a baby.

A woman's right to know: HPV and cervical cancer

The HPV test came back positive – what now? Should women be worried? What should they do next?

Live well, work well

Fostering a culture of health and wellbeing among employees

Responding to natural disasters sustainably

For communities that have experienced a major natural disaster, we support community rebuilding and humanitarian projects.

Strengthening communities

We are committed to building stronger communities and responding to natural disasters sustainably.

Our approach to philanthropy

We engage in philanthropic activities that make a lasting impact and strengthen communities.

Transnet-Phelophepa healthcare train

The Transnet-Phelophepa trains are mobile healthcare clinics that travel nine months out of the year to areas of rural South Africa.

The role of diagnostics in fertility and pregnancy

Learn more about advanced screening and diagnostics tests and their role in preconception and pregnancy.

Roche at RCOG

The annual Royal College of Obstetrics and Gynaecology (RCOG) World Congress brings together health professionals to learn from each other and exchange views.

Better together: Helping one million people with diabetes

Ask anybody with diabetes: managing it is time consuming, exhausting and very annoying.

Of bonds and benefits

Two made-in-Japan collaborations strengthen both Roche and its partners.

Changing the colorectal cancer story

Two days after being admitted to hospital with stomach pains, Eve Bukowski woke up to the news we all fear.

Pioneering a new era in cancer diagnostics

Effective therapies start with an accurate diagnosis. Diagnostics advancements are helping patients to receive personalised treatments.

Women’s health at every stage of life

Every woman’s journey through life is her own, yet all face similar choices and challenges. Health is critical at every stage of this journey.

Roche on World Cancer Day

We are happy to join the global cancer community on this important day to unite behind a shared goal: to end cancer.

Making HIV testing accessible

The Global Access Programme makes HIV viral load tests and the early detection of infections in infants possible in countries that are most affected by the disease.

Our Approach to Cancer Immunotherapy

Roche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.

About the importance of funding

Four key factors need to be in place to successfully treat a patient, with funding being the most controversial one.

About the importance of healthcare capacity

Healthcare capacity is one of four key factors that need to be in place to successfully treat a patient.

About the importance of diagnosis

Four key factors need to be in place to successfully treat a patient, with diagnosis being one of them.

About the importance of disease awareness

Four key factors need to be in place to successfully treat a patient, the first factor is disease awareness.

Our approach to increase access to healthcare

Access to healthcare is a complex challenge. Four key factors need to be in place to improve access to quality healthcare.

Always trying to err on the side of drug safety

Keeping its medicines safe for the people who need them is at the core of our remit.

Digital solutions supporting rheumatoid arthritis community

It has become natural for people to seek information or advice about their health online. Learn about three solutions we developed for the European RA community.

The value of diagnostics in heart failure management

Heart failure affects millions of people and despite improvement in care, management remains challenging. Biomarkers can help patients at every stage of care.

The many faces of breast cancer

Each women is unique. But breast cancer doesn’t care. It can happen to anyone. And when it does happen, each woman’s breast cancer is as individual as she is.

Mesothelioma: What could possibly link this rare cancer to the ill-fated Titanic?

What could possibly link this rare cancer to the ill-fated Titanic?

Busting myths in lung cancer

How much do you really know about lung cancer? Our interactive flashcards bust some common myths about lung cancer.

Shedding light on progression in MS

How Roche is paving the way for better understanding of MS disease progression and monitoring.

Expecting more for people with PPMS

Dr. Jerome de Seze, explains how recent clinical advances mean more and more people are being diagnosed with PPMS.

MS measurements explained

How we define the ways in which multiple sclerosis can be measured.

Primary progressive MS: Different perspectives

Dr. de Seze and Craig Milverton, who lives with primary progressive multiple sclerosis (PPMS), share their experiences managing and living with this form of MS.

Roche at the World Congress on Lung Cancer

Check out how we are transforming the diagnosis and management of lung cancer.

What is Life?- Live Streaming with Paul Nurse.

Watch the live stream of Nobel Prize winner Sir Paul Nurse

The realities of pursuing the cure for cancer

Cindy Perettie, our Global Head of Oncology Strategy, provides her personal perspective on the challenges of leading the cure for cancer.

Protecting against progression

Dr. Traboulsee, University of British Columbia in Vancouver, discusses the importance of brain health and early treatment for people with multiple sclerosis.

Beyond the immunity cycle

Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.

Roche in Alzheimer’s disease

Alzheimer’s disease has far-reaching impact on individuals, caregivers, families and society. Learn how Roche is tackling this looming global crisis.

Our response to cancer always starts with the science

Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.

Creating value through partnerships

Partnering builds on our culture, one in which we listen to a potential partner and structure a collaboration that meets both parties’ needs.

The role of companion diagnostics in breast cancer

The right treatment decision is essential for a breast cancer patient’s well-being.

Buttons - daily enemies for people with rheumatoid arthritis

New clothing collection designed to overcoming issues that people with RA face when getting dressed.

Rheumatoid arthritis through the lens of an Slovenian artist

A photographer captures what it means to live with the consequences of rheumatoid arthritis.

Providing a helping hand for people with rheumatoid arthritis

A collaboration with the Brazilian patient advocacy group helps to improve the quality of life of people living with RA.

Life with rheumatoid arthritis through pictures and words

The three artists captured what living with the disease means to people with rheumatoid arthritis.